Twitter LinkedIn
    Friday, March 24
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»Blackstone, Carlyle mull $25bn bid for Novartis generics arm
    Deals & Transactions

    Blackstone, Carlyle mull $25bn bid for Novartis generics arm

    February 2, 2022Updated:February 2, 20221 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    FILE PHOTO: Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Two private equity giants are reportedly discussing launching a joint bid for the generics unit of pharma giant Novartis, according to reports.

    Blackstone and Carlyle Group have discussed teaming up to launch a bid for the Sandoz generics arm of the Swiss drugmaker which could be valued at $25bn (£18.5bn), Bloomberg reported.

    Sandoz generated $9.7 billion in sales last year and German news outlet Handelsblat reported in November that the arm was on sale for of $21.6 billion.

    Read more: City AM

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    deals PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Thyssenkrupp shares move higher on report of CVC interest in steel unit

    March 21, 2023

    BlackRock Not Working on Rival Bid for Credit Suisse

    March 18, 2023

    University of California invests $4 bn in redemption-stricken REIT

    January 3, 2023

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    Comments are closed.

    Other Articles

    Diageo buys hard seltzer brand Lone River Ranch Water

    March 9, 2021

    KKR deploys record US$12.5 billion as firm ramped up dealmaking

    February 11, 2021

    Advent International Weighing Options for $1 Billion Mattress Maker

    February 6, 2021

    KKR Hires Ford Motor Veteran Pamela Alexander to Oversee Philanthropy

    April 12, 2022

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?